E.E. Geduld’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

E.E. Geduld’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-111	Closed	-$81K	–	227
2015 Q3	$81K	Sell	111 -167	-60%	-$179K	0.08%	137
2015 Q2	$225K	Buy	+278	New	+$178K	0.14%	162

Other funds holding EVFM

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

E.E. Geduld's EVFM Position: Q4 2015 in Review

E.E. Geduld sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2015, closing a stake of 111 shares — an estimated $81K sold.

E.E. Geduld first reported a position in EVFM in Q2 2015 and held it in 2 quarters. The position peaked at $225K in Q2 2015. 24 funds tracked by Wall St. Rank hold EVFM as of Q4 2015.

E.E. Geduld reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
E.E. Geduld sold 111 Evofem Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $81K.
E.E. Geduld first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
E.E. Geduld's Evofem Biosciences, Inc. Common Stock position peaked at $225K in Q2 2015.
24 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2015.

Based on E.E. Geduld's 13F filing for Q4 2015, filed 2 Feb 2016.